Ganga Pharmaceuticals Limited reported audited earnings results for fourth quarter and full year ended March 31, 2017. For the quarter, the company reported total income from operations of INR 18.377 million, profit from operations before other income and finance costs and exceptional items of INR 2.076 million, profit from ordinary activities before tax of INR 0.52 million, net profit of INR 0.387 million or INR 0.13 basic and diluted per share compared to the total income from operations of INR 15.478 million, profit from operations before other income and finance costs and exceptional items of INR 1.723 million, profit from ordinary activities before tax of INR 0.072 million, net profit of INR 0.02 million or INR 0.01 basic and diluted per share for the same quarter a year ago. For the year, the company reported total income from operations of INR 31.673 million, profit from operations before other income and finance costs and exceptional items of INR 4.23 million, profit from ordinary activities before tax of INR 1.058 million, net profit of INR 0.742 million or INR 0.18 basic and diluted per share compared to the total income from operations of INR 27.645 million, profit from operations before other income and finance costs and exceptional items of INR 3.96 million, profit from ordinary activities before tax of INR 0.701 million, net profit of INR 0.487 million or INR 0.12 basic and diluted per share for the previous year.